Compile Data Set for Download or QSAR
Found 24 Enz. Inhib. hit(s) with all data for entry = 3372
TargetBifunctional epoxide hydrolase 2(Homo sapiens (Human))
AstraZeneca

LigandPNGBDBM398054(US10322118, Urea-Based Scaffold Entry 1)copy SMILEScopy InChI
Affinity DataIC50: 3.80nMAssay Description:The first step in characterizing the two compounds identified by high throughput screening was to verify that the inhibition was reproducible using f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KW5JC9US Patent
TargetBifunctional epoxide hydrolase 2(Homo sapiens (Human))
AstraZeneca

LigandPNGBDBM50327827(1-(4-Nitrophenyl)-3-(1-propionylpiperidin-4-yl)ure...)copy SMILEScopy InChI
Affinity DataIC50: 38nMAssay Description:The first step in characterizing the two compounds identified by high throughput screening was to verify that the inhibition was reproducible using f...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KW5JC9US Patent
TargetPutative hydrolase(Pseudomonas aeruginosa (strain UCBPP-PA14))
AstraZeneca

LigandPNGBDBM398056(US10322118, Urea-Based Scaffold Entry 4)copy SMILEScopy InChI
Affinity DataIC50: 1.50E+3nMAssay Description:The first step in characterizing the two compounds identified by high throughput screening was to verify that the inhibition was reproducible using f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KW5JC9US Patent
TargetPutative hydrolase(Pseudomonas aeruginosa (strain UCBPP-PA14))
AstraZeneca

LigandPNGBDBM398055(US10322118, Urea-Based Scaffold Entry 3)copy SMILEScopy InChI
Affinity DataIC50: 1.80E+3nMAssay Description:The first step in characterizing the two compounds identified by high throughput screening was to verify that the inhibition was reproducible using f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KW5JC9US Patent
TargetPutative hydrolase(Pseudomonas aeruginosa (strain UCBPP-PA14))
AstraZeneca

LigandPNGBDBM50385105(CHEMBL2035874 | US10322118, Entry 8b)copy SMILEScopy InChI
Affinity DataIC50: 2.70E+3nMAssay Description:The first step in characterizing the two compounds identified by high throughput screening was to verify that the inhibition was reproducible using f...More data for this Ligand-Target Pair
TargetPutative hydrolase(Pseudomonas aeruginosa (strain UCBPP-PA14))
AstraZeneca

LigandPNGBDBM18864(3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]pr...)copy SMILEScopy InChI
Affinity DataIC50: 4.40E+3nMAssay Description:The first step in characterizing the two compounds identified by high throughput screening was to verify that the inhibition was reproducible using f...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KW5JC9US Patent
TargetPutative hydrolase(Pseudomonas aeruginosa (strain UCBPP-PA14))
AstraZeneca

LigandPNGBDBM18862(2-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]ac...)copy SMILEScopy InChI
Affinity DataIC50: 4.70E+3nMAssay Description:The first step in characterizing the two compounds identified by high throughput screening was to verify that the inhibition was reproducible using f...More data for this Ligand-Target Pair
TargetPutative hydrolase(Pseudomonas aeruginosa (strain UCBPP-PA14))
AstraZeneca

LigandPNGBDBM11639(4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyraz...)copy SMILEScopy InChI
Affinity DataIC50: 7.40E+3nMAssay Description:The first step in characterizing the two compounds identified by high throughput screening was to verify that the inhibition was reproducible using f...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KW5JC9US Patent
TargetPutative hydrolase(Pseudomonas aeruginosa (strain UCBPP-PA14))
AstraZeneca

LigandPNGBDBM398043(US10322118, Entry 1)copy SMILEScopy InChI
Affinity DataIC50: 2.00E+4nMAssay Description:The first step in characterizing the two compounds identified by high throughput screening was to verify that the inhibition was reproducible using f...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KW5JC9US Patent
TargetPutative hydrolase(Pseudomonas aeruginosa (strain UCBPP-PA14))
AstraZeneca

LigandPNGBDBM398047(US10322118, Entry 5)copy SMILEScopy InChI
Affinity DataIC50: 2.10E+4nMAssay Description:The first step in characterizing the two compounds identified by high throughput screening was to verify that the inhibition was reproducible using f...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KW5JC9US Patent
TargetBifunctional epoxide hydrolase 2(Homo sapiens (Human))
AstraZeneca

LigandPNGBDBM398060(US10322118, Urea-Based Scaffold Entry 8)copy SMILEScopy InChI
Affinity DataIC50: 3.33E+4nMAssay Description:The first step in characterizing the two compounds identified by high throughput screening was to verify that the inhibition was reproducible using f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KW5JC9US Patent
TargetPutative hydrolase(Pseudomonas aeruginosa (strain UCBPP-PA14))
AstraZeneca

LigandPNGBDBM50327827(1-(4-Nitrophenyl)-3-(1-propionylpiperidin-4-yl)ure...)copy SMILEScopy InChI
Affinity DataIC50: 4.00E+4nMAssay Description:The first step in characterizing the two compounds identified by high throughput screening was to verify that the inhibition was reproducible using f...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KW5JC9US Patent
TargetPutative hydrolase(Pseudomonas aeruginosa (strain UCBPP-PA14))
AstraZeneca

LigandPNGBDBM398046(US10322118, Entry 4)copy SMILEScopy InChI
Affinity DataIC50: 8.00E+4nMAssay Description:The first step in characterizing the two compounds identified by high throughput screening was to verify that the inhibition was reproducible using f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KW5JC9US Patent
TargetPutative hydrolase(Pseudomonas aeruginosa (strain UCBPP-PA14))
AstraZeneca

LigandPNGBDBM398045(US10322118, Entry 3)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+5nMAssay Description:The first step in characterizing the two compounds identified by high throughput screening was to verify that the inhibition was reproducible using f...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KW5JC9US Patent
TargetBifunctional epoxide hydrolase 2(Homo sapiens (Human))
AstraZeneca

LigandPNGBDBM11639(4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyraz...)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+5nMAssay Description:The first step in characterizing the two compounds identified by high throughput screening was to verify that the inhibition was reproducible using f...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KW5JC9US Patent
TargetPutative hydrolase(Pseudomonas aeruginosa (strain UCBPP-PA14))
AstraZeneca

LigandPNGBDBM398059(US10322118, Urea-Based Scaffold Entry 7)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+5nMAssay Description:The first step in characterizing the two compounds identified by high throughput screening was to verify that the inhibition was reproducible using f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KW5JC9US Patent
TargetPutative hydrolase(Pseudomonas aeruginosa (strain UCBPP-PA14))
AstraZeneca

LigandPNGBDBM398058(US10322118, Urea-Based Scaffold Entry 6)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+5nMAssay Description:The first step in characterizing the two compounds identified by high throughput screening was to verify that the inhibition was reproducible using f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KW5JC9US Patent
TargetPutative hydrolase(Pseudomonas aeruginosa (strain UCBPP-PA14))
AstraZeneca

LigandPNGBDBM398057(US10322118, Urea-Based Scaffold Entry 5)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+5nMAssay Description:The first step in characterizing the two compounds identified by high throughput screening was to verify that the inhibition was reproducible using f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KW5JC9US Patent
TargetPutative hydrolase(Pseudomonas aeruginosa (strain UCBPP-PA14))
AstraZeneca

LigandPNGBDBM398054(US10322118, Urea-Based Scaffold Entry 1)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+5nMAssay Description:The first step in characterizing the two compounds identified by high throughput screening was to verify that the inhibition was reproducible using f...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KW5JC9US Patent
TargetPutative hydrolase(Pseudomonas aeruginosa (strain UCBPP-PA14))
AstraZeneca

LigandPNGBDBM50060966(4-Phenoxy-benzoic acid | CHEMBL107518 | US10322118...)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+5nMAssay Description:The first step in characterizing the two compounds identified by high throughput screening was to verify that the inhibition was reproducible using f...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KW5JC9US Patent
TargetPutative hydrolase(Pseudomonas aeruginosa (strain UCBPP-PA14))
AstraZeneca

LigandPNGBDBM50334276(4-phenoxyaniline | CHEMBL249550 | US10322118, Entr...)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+5nMAssay Description:The first step in characterizing the two compounds identified by high throughput screening was to verify that the inhibition was reproducible using f...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KW5JC9US Patent
TargetPutative hydrolase(Pseudomonas aeruginosa (strain UCBPP-PA14))
AstraZeneca

LigandPNGBDBM398051(US10322118, Entry 9)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+5nMAssay Description:The first step in characterizing the two compounds identified by high throughput screening was to verify that the inhibition was reproducible using f...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KW5JC9US Patent
TargetPutative hydrolase(Pseudomonas aeruginosa (strain UCBPP-PA14))
AstraZeneca

LigandPNGBDBM398048(US10322118, Entry 6)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+5nMAssay Description:The first step in characterizing the two compounds identified by high throughput screening was to verify that the inhibition was reproducible using f...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KW5JC9US Patent
TargetPutative hydrolase(Pseudomonas aeruginosa (strain UCBPP-PA14))
AstraZeneca

LigandPNGBDBM50115668(3,5-dimethyl-4-(4'-hydroxy-3'-isopropylbenzyl)phen...)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+5nMAssay Description:The first step in characterizing the two compounds identified by high throughput screening was to verify that the inhibition was reproducible using f...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KW5JC9US Patent